thymidine has been researched along with Leukemia, Myelomonocytic, Chronic in 1 studies
Leukemia, Myelomonocytic, Chronic: A myelodysplastic-myeloproliferative disease characterized by monocytosis, increased monocytes in the bone marrow, variable degrees of dysplasia, but an absence of immature granulocytes in the blood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuda, T | 1 |
| Kakihara, T | 1 |
| Kamishima, T | 1 |
| Ohnishi, Y | 1 |
| Naito, M | 1 |
| Kishi, K | 1 |
| Shibata, A | 1 |
1 other study available for thymidine and Leukemia, Myelomonocytic, Chronic
| Article | Year |
|---|---|
Different effects of various hematopoietic growth factors on myelomonocytic cell line (KY-821) and its drug-resistant sublines.
Topics: Animals; Antibodies, Monoclonal; Antigens, Neoplasm; Antigens, Surface; Antineoplastic Agents; Drug | 1993 |